From discovery to the clinic - with confidence. Ensure the quality of the data that supports your program.
Advancing a therapeutic candidate from discovery to the clinic demands rigorous, well‑designed, and well‑documented pre‑clinical testing. Whether studies are conducted in house or outsourced the teams responsible for them are required to be adequately trained and equipped with knowledge to operate within a compliant quality framework.

The Organisation for Economic Co-operation and Development (OECD) Principles of Good Laboratory Practice (GLP) define the quality system governing the planning, conduct, monitoring, recording, reporting, and archiving of non‑clinical safety studies. This short course introduces the foundational principles, expectations, and operational requirements of both OECD Principles of GLP and the US FDA CFR Part 58 GLP for Non-Clinical Studies as they apply to early‑stage drug development in preparation for non‑clinical safety studies.

Our full-day in person course is designed for organisations transitioning from exploratory R&D into regulated non‑clinical safety testing, where assay development, method qualification, and production of GLP batches are critical to study integrity, traceability and reproducibility.